# HYRIMOZ

NDC: 61314-476
Generic name: adalimumab-adaz
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230701

FDA application: BLA761071

## Active ingredients

- ADALIMUMAB: 20 mg/.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61314-476"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61314-476
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1ac7d061-3380-468c-b077-c05f8dfbc829